Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis

被引：0
|
作者：
Saag, K. G. [1 ]
Shane, E. [2 ]
Boonen, S. [3 ]
Donley, D. W. [4 ]
Marin, F. [4 ]
Warner, M. R. [4 ]
Taylor, K. A. [4 ]
Dalsky, G. R. [4 ]
Marcus, R. [4 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
[2] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA
[3] Katholieke Univ Leuven, Div Geriatr Med, Louvain, Belgium
[4] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [21] Serum osteocalcin concentrations in patients with glucocorticoid-induced osteoporosis treated with alendronate or teriparatide
    Eastell, R.
    Chen, P.
    Saag, K. G.
    Burshell, A. L.
    Warner, M. R.
    Dalsky, G. R.
    Krege, J. H.
    [J]. BONE, 2009, 44 (02) : S441 - S441
  • [22] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
    de Nijs, Ron N. J.
    Jacobs, Johannes W. G.
    Lems, Willem F.
    Laan, Roland F. J.
    Algra, Ale
    Huisman, Anne-Margriet
    Buskens, Erik
    de laet, Chris E. D.
    Oostveen, Ans C. M.
    Geusens, Piet P. M. M.
    Bruyn, George A. W.
    Dijkmans, Ben A. C.
    Bijlsma, Johannes W. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07): : 675 - 684
  • [23] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
    Minisola, Salvatore
    Scillitani, Alfredo
    Romagnoli, Elisabetta
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20): : 2156 - 2157
  • [24] Teriparatide versus alendronate in glucocorticoid-induced osteoporosis: Results of a subgroup analysis in men, pre- and postmenopausal women
    Langdahl, B.
    Dobnig, H.
    Zanchetta, J. R.
    Maricic, M.
    Krohn, K.
    See, K.
    Marin, F.
    Warner, M. R.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S251 - S251
  • [25] Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment
    Hirooka, Yasuaki
    Nozaki, Yuji
    Inoue, Asuka
    Li, Jinhai
    Shiga, Toshihiko
    Kishimoto, Kazuya
    Sugiyama, Masafumi
    Kinoshita, Koji
    Funauchi, Masanori
    Matsumura, Itaru
    [J]. BONE REPORTS, 2020, 13
  • [26] The efficiency and safety of alendronate versus teriparatide for treatment glucocorticoid-induced osteoporosis: A meta-analysis and systematic review of randomized controlled trials
    Liu, Zhi-Ming
    Zhang, Min
    Zong, Yuan
    Zhang, Ding
    Shen, Zhu-Bin
    Guan, Xiao-Qing
    Yin, Fei
    [J]. PLOS ONE, 2022, 17 (05):
  • [27] Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Effects of gender and menopausal status-24-month results
    Dobnig, H.
    Warner, M. R.
    Langdahl, B. L.
    Moericke, R.
    See, K.
    Marin, F.
    [J]. BONE, 2009, 44 (02) : S235 - S235
  • [28] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis - Reply
    de Nijs, Ron N. J.
    Jacobs, Johannes W. G.
    Bijlsma, Johannes W. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20): : 2157 - 2157
  • [29] Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis
    Devogelaer, Jean-Pierre
    Adler, Robert A.
    Recknor, Chris
    See, Kyoungah
    Warner, Margaret R.
    Wong, Mayme
    Krohn, Kelly
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) : 141 - 148
  • [30] Effects of Teriparatide Versus Alendronate for Treating Glucocorticoid-Induced Osteoporosis Thirty-Six-Month Results of a Randomized, Double-Blind, Controlled Trial
    Saag, Kenneth G.
    Zanchetta, Jose R.
    Devogelaer, Jean-Pierre
    Adler, Robert A.
    Eastell, Richard
    See, Kyoungah
    Krege, John H.
    Krohn, Kelly
    Warner, Margaret R.
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (11): : 3346 - 3355
12345